WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, vol.18, no.1, pp.34-38, 2014 (ESCI)
Article / Article
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY
Emerging Sources Citation Index (ESCI), Scopus
triple-negative breast cancer, adiponectin, immunohistochemistry, prognosis
Bursa Uludag University Affiliated:
Introduction: Triple-negative breast cancers (TNBCs) -which lack the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2)-have no established markers that can be used for prognostic stratification. As adiponectin has been previously implicated in a more aggressive phenotype of primary breast cancer, we explored the relation between adiponectin immunohistochemical expression and prognosis in TNBCs.